Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

Pharmaceutical Supply – Oral Contraceptive Tablets

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract involves the supply of FDA-approved generic oral contraceptive tablets containing Norgestrel and Ethinyl Estradiol, precisely aligned with the National Stock Number 6505011479542 and all applicable Defense Logistics Agency medical procurement standards. These tablets must comply with stringent quality, safety, and manufacturing specifications required for federal medical use, ensuring consistent efficacy and reliability for distribution through military and defense healthcare channels. The product is subject to rigorous regulatory oversight and must meet all current Good Manufacturing Practices as defined by the FDA and DLA. The contract is categorized as a subcontract under NAICS code 325412, which pertains to pharmaceutical and botanical product manufacturing, with the Defense Logistics Agency acting as the procuring entity under the Department of Defense. The solicitation was posted on July 14, 2026, and the performance and delivery are expected to conform to DLA’s logistical and supply chain requirements, though specific delivery locations and points of contact are not detailed. The contract reference is linked through the DIBBS system, indicating formal award and tracking under the contract numbers SPE2DX25D9900 and SPE2DP26F7629 with a line item count of 7121.

General Info

Supply of FDA-approved Norgestrel/Ethinyl Estradiol tablets for DLA under military medical standards.

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

Not specified

Set-Aside

NONE

Documents

This scope was carved out of SPE2DP26F7629.

The full solicitation package (2 documents), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

NORGESTREL AND ETHINYL ESTRADIOL TABLETS

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

Posted

subcontract

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Logistics Agency
ContactsNo contacts available
OfficeN/A
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Supply of FDA-approved generic oral contraceptive tablets (Norgestrel and Ethinyl Estradiol) meeting NSN 6505011479542 specifications and DLA medical procurement standards.

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
DIBBS
DIBUCAINE OINTMENT
Solicitation # SPE2DP-27-T-0233
Solicitation SPE2DP-27-T-0233, issued by the DLA Troop Support Medical Supply Chain Pharm FSA, is a request for quotations for the procurement of Dibucaine Ointment, USP. The required product is a rectal ointment containing 1 percent dibucaine as the active ingredient, supplied in a collapsible tube with a rectal applicator. Each unit of issue consists of one package containing one ounce or 28 grams. The product must be stored between 15 and 30 degrees Celsius and is intended for external, rectal administration. The procurement specifies a quantity of one package with a required delivery date of November 5, 2026, and a delivery lead time of 20 days after order. The contract mandates strict adherence to quality and packaging standards, including USP standards, MIL-STD-129 for marking, and Medical Marking Standard No. 1. Packaging must comply with DLA Packaging Requirements for Procurement (RP001) and ASTM D3951 for non-hazardous materials, while hazardous materials must follow TQ requirement IP025 and FED-STD-313. Delivery is FOB Destination, with inspection and acceptance also occurring at the destination. Payment and receiving reports must be processed electronically through the Wide Area WorkFlow (WAWF) system. Key regulatory and legal requirements include compliance with the Buy American Act, the Berry Amendment, and DFARS regulations regarding the safeguarding of covered defense information and the prohibition of certain telecommunications equipment. Offerors must be registered in the System for Award Management (SAM) and provide necessary representations and certifications regarding their business size and socioeconomic status. Quotations are to be submitted via the DIBBS portal by November 9, 2026.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 8 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
SODIUM PERBORATE
Solicitation # SPE2DP-27-T-0229
Solicitation SPE2DP-27-T-0229 is a procurement by the Defense Logistics Agency for one 100 gram bottle of Sodium Perborate in powder form, identified by NSN 6505-01-307-3268. The item is a regulated FDA drug or device and is classified as a Type I (Code Q) item with a non-extendable shelf life of 36 months. Strict storage requirements apply, including avoiding high humidity and maintaining temperatures below 32 degrees Celsius (90 degrees Fahrenheit), while keeping the material away from flammable or combustible substances. Delivery is required within 20 days after receipt of order, with a destination FOB and a required delivery date of August 6, 2026, for shipment to the USS Portland LPD 27 via DLA Distribution San Diego. The contract mandates strict adherence to Medical Marking Standard No. 1, which supersedes MIL-STD-129 for material marking. Packaging must comply with DLA Packaging Requirements for Procurement (RP001) and ASTM D3951 for non-hazardous materials, though TQ requirement IP025 and FED-STD-313 apply if the material is deemed hazardous. Inspection and acceptance will occur at the destination per FAR 52.246-2. The procurement incorporates various federal and defense clauses, including the Buy American Act, DFARS cybersecurity reporting requirements, and the DLA Master List of Technical and Quality Requirements. Invoicing and payment must be processed electronically through the Wide Area WorkFlow system.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 8 hours ago

DEADLINE

in 6 days
View Details

More opportunities from Department Of Defense → Defense Logistics Agency

Same awarding agency

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS